|
Product cited in:
|
Chabaud, Lubberts, Joosten, van Den Berg, Miossec: "IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis." in: Arthritis research, Vol. 3, Issue 3, pp. 168-77, 2001 (PubMed).
Woltman, de Haij, Boonstra, Gobin, Daha, van Kooten: "Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells." in: Journal of the American Society of Nephrology : JASN, Vol. 11, Issue 11, pp. 2044-55, 2000 (PubMed).
Aarvak, Chabaud, Miossec, Natvig: "IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 3, pp. 1246-51, 1999 (PubMed).
Chabaud, Durand, Buchs, Fossiez, Page, Frappart, Miossec: "Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium." in: Arthritis and rheumatism, Vol. 42, Issue 5, pp. 963-70, 1999 (PubMed).
Chabaud, Fossiez, Taupin, Miossec: "Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 161, Issue 1, pp. 409-14, 1998 (PubMed).
Van Kooten, Boonstra, Paape, Fossiez, Banchereau, Lebecque, Bruijn, De Fijter, Van Es, Daha: "Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection." in: Journal of the American Society of Nephrology : JASN, Vol. 9, Issue 8, pp. 1526-34, 1998 (PubMed).
|
